OptimizeRx Corp (OPRX) stock
OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3029% below fair value
$6.70−0.31 (-4.42%)
Close on Nov 20, 2026Market cap $126.20MP/E 27.9Yield –
OptimizeRx gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
OptimizeRx's gross profit for the twelve months ending Jun 30, 2026 was $72.24M, up 7.1% year over year. For fiscal 2025 it was $73.60M, up 23.9% from the year before. Over ten years it grew 35.2% a year on average. The highest annual figure on record is $73.60M in fiscal 2025.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $73.60M | +23.9% |
| FY2024 | Dec 31, 2024 | $59.38M | +38.4% |
| FY2023 | Dec 31, 2023 | $42.90M | +10.1% |
| FY2022 | Dec 31, 2022 | $38.97M | +9.3% |
| FY2021 | Dec 31, 2021 | $35.64M | +47.8% |
| FY2020 | Dec 31, 2020 | $24.11M | +56.1% |
| FY2019 | Dec 31, 2019 | $15.44M | +26.5% |
| FY2018 | Dec 31, 2018 | $12.21M | +105.1% |
| FY2017 | Dec 31, 2017 | $5.95M | +37.2% |
| FY2016 | Dec 31, 2016 | $4.34M | +20.6% |
| FY2015 | Dec 31, 2015 | $3.60M | +9.7% |
| FY2014 | Dec 31, 2014 | $3.28M | +16.4% |
| FY2013 | Dec 31, 2013 | $2.82M | +50.4% |
| FY2012 | Dec 31, 2012 | $1.87M | – |
Quarterly gross profit
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $15.69M | -15.8% |
| Q1 FY2026 | Mar 31, 2026 | $14.93M | +11.9% |
| Q4 FY2025 | Dec 31, 2025 | $24.10M | +9.4% |
| Q3 FY2025 | Sep 30, 2025 | $17.52M | +30.3% |
| Q2 FY2025 | Jun 30, 2025 | $18.64M | +59.2% |
| Q1 FY2025 | Mar 31, 2025 | $13.34M | +9.3% |
| Q4 FY2024 | Dec 31, 2024 | $22.02M | +23.4% |
| Q3 FY2024 | Sep 30, 2024 | $13.45M | +37.2% |
| Q2 FY2024 | Jun 30, 2024 | $11.70M | +49.6% |
| Q1 FY2024 | Mar 31, 2024 | $12.20M | +64.2% |
| Q4 FY2023 | Dec 31, 2023 | $17.84M | +43.3% |
| Q3 FY2023 | Sep 30, 2023 | $9.80M | +21.0% |
| Q2 FY2023 | Jun 30, 2023 | $7.83M | -36.9% |
| Q1 FY2023 | Mar 31, 2023 | $7.43M | -18.1% |
| Q4 FY2022 | Dec 31, 2022 | $12.45M | +54.8% |
| Q1 FY2022 | Mar 31, 2022 | $8.10M | +32.3% |
| Q4 FY2021 | Dec 31, 2021 | $12.39M | +44.0% |
| Q3 FY2021 | Sep 30, 2021 | $9.08M | +50.9% |
| Q2 FY2021 | Jun 30, 2021 | $8.04M | +56.4% |
| Q1 FY2021 | Mar 31, 2021 | $6.12M | +41.0% |
| Q4 FY2020 | Dec 31, 2020 | $8.60M | +99.2% |
| Q3 FY2020 | Sep 30, 2020 | $6.01M | +65.9% |
| Q2 FY2020 | Jun 30, 2020 | $5.14M | +25.7% |
| Q1 FY2020 | Mar 31, 2020 | $4.34M | +38.0% |
| Q2 FY2019 | Jun 30, 2019 | $4.32M | +50.9% |
| Q1 FY2019 | Mar 31, 2019 | $3.63M | +72.3% |
| Q4 FY2018 | Dec 31, 2018 | $4.09M | +62.2% |
| Q3 FY2018 | Sep 30, 2018 | $3.15M | +124.9% |
| Q2 FY2018 | Jun 30, 2018 | $2.86M | +127.1% |
| Q1 FY2018 | Mar 31, 2018 | $2.10M | +173.1% |
| Q4 FY2017 | Dec 31, 2017 | $2.52M | +77.7% |
| Q3 FY2017 | Sep 30, 2017 | $1.40M | +31.6% |
| Q2 FY2017 | Jun 30, 2017 | $1.26M | +27.2% |
| Q1 FY2017 | Mar 31, 2017 | $770.34K | -11.1% |
| Q4 FY2016 | Dec 31, 2016 | $1.42M | – |
| Q3 FY2016 | Sep 30, 2016 | $1.06M | – |
| Q2 FY2016 | Jun 30, 2016 | $990.47K | – |
| Q1 FY2016 | Mar 31, 2016 | $866.74K | – |
See a number that looks wrong?